Overview
High-Quality Multiple Myeloma for PBMC Research
Human Multiple Myeloma PBMC products are sourced from donors clinically diagnosed with Multiple Myeloma and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune evasion and treatment resistance.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed multiple myeloma donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStore® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
Donor Metadata
- Verified multiple myeloma diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional multiple myeloma-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in multiple myeloma pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Multiple Myeloma PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact to confirm documentation and compliance needs.
Protocol and Documentation
Resources and Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.